TEAM OF SCIENTISTS
The Company has assembled an outstanding team of scientists and clinicians to assist the company in a consulting basis with its cancer drug development program.
The main scientific founder of Oncolin is Dr. Waldemar Priebe, Professor at the University of Texas M. D. Anderson Cancer Center. Oncolin has rights to several of Dr. Priebe’s patents through M. D. Anderson Cancer Center and HPI.
Dr. Priebe has a worldwide reputation for discovering and assisting development of novel cancer therapeutics. He currently has several drugs in clinical development with several about to enter clinical trials. He is the author of 157 peer reviewed papers and the lead inventor on 40 patent and patent applications. |